MedTrace Logo

AcrySof IQ Toric A-Code Post-Market Clinical Study

NCT03350503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2022-12-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to clinically confirm the rotational stability of a modified AcrySof IQ toric intraocular lens (IOL) in a Japanese population.

Conditions

  • Cataract
  • Astigmatism

Interventions

DEVICE

AcrySof IQ Toric A-code IOL

Intended to provide visual acuity, including astigmatism correction, over the lifetime of the cataract patient

PROCEDURE

Cataract surgery

Removal of cataractous lens and implantation of IOL

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Expert Clinical Project Lead, CDMA Surgical · Alcon Research, LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-30
Primary Completion
2019-05-23
Completion
2021-12-17
FDA Device
Yes

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03350503 on ClinicalTrials.gov